SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

Aventus Network (AVT) is trending as the community highlights its recent move to decentralize governance via the Aventus DAO in the UAE and the appointment of strategic leadership to drive enterprise adoption. Investors are buzzing about the project's Polkadot-integrated infrastructure and the potential for a breakout, though many are closely monitoring trading volume to see if it can sustain a move past current resistance levels.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor is gaining momentum as investors draw parallels between its tokenomics and Bitcoin, highlighting its fixed 21 million supply cap and an upcoming halving event as key catalysts for scarcity. The community is actively discussing the platform's role in decentralized AI infrastructure, with many traders framing it as a long-term play while tracking institutional interest and the growth of its subnet ecosystem.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as investors debate its potential for a supply-driven breakout, with many citing its status as a mature proof-of-work asset as a long-term advantage. While some in the community express frustration over recent underperformance and lack of retail volume, others are actively accumulating during current consolidation, pinning their hopes on regulatory developments and institutional adoption.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing significant volatility following an earnings report that featured a strong profit beat but raised concerns regarding revenue growth and future guidance timelines. Despite the selling pressure, the community remains intensely focused on the company's $13 billion AI connectivity backlog and recent insider buying from leadership, fueling ongoing debates over whether the stock is a long-term infrastructure play or a speculative turnaround narrative.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is trending as investors debate the impact of an upcoming 1-for-5 reverse stock split amidst ongoing volatility in its underlying asset, MicroStrategy. Community discussion remains polarized, with some traders leveraging the fund for aggressive weekly income strategies, while many others are expressing frustration over consistent NAV erosion and the declining value of distributions.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending as investors weigh recent board appointments of financial restructuring experts against long-standing concerns over debt and BetterHelp's growth trajectory. The community is actively debating the stock's significant undervaluation relative to its revenue and sector peers, with many traders positioning for a potential volatility spike heading into the upcoming earnings report.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending as investors bet on the companys role in edge AI and rugged compute for defense, fueled by recent multi-million dollar Navy P-8A Poseidon contract awards. Community discourse is highly bullish, with many traders discussing potential short squeezes, accumulation patterns, and the massive long-term revenue potential of rumored $200M government contracts in the defense and robotics sectors.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASP Isotopes is experiencing high volatility as shareholders debate the company's recent strategic pivot into early-stage biotech investments, with many expressing frustration over persistent delays in core isotope production and feedstock deliveries. While some investors remain optimistic about the firm's long-term potential in HALEU and semiconductor supply chains, current community sentiment is increasingly divided between those seeking immediate revenue milestones and those betting on future institutional growth.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is trending following the announcement that activist investor Elliott Investment Management has taken a 10% stake in the company to push for significant board and operational changes. Shareholders are actively debating whether this intervention will finally force a turnaround for the long-struggling operator, with many closely watching for potential leadership shifts or a future buyout.

Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. The Real Estate segment includes management of opportunistic real estate funds, Core+ real estate funds, high-yield real estate debt funds, and liquid real estate debt funds. The Private Equity segment consists of management of flagship corporate private equity funds, sector and geographically focused corporate private equity funds, core private equity funds, an opportunistic investment platform, a secondary fund of funds business, infrastructure-focused funds, a life sciences investment platform, a growth equity investment platform, a multi-asset investment program for eligible high net worth investors and a capital markets services business. The Credit and Insurance segment refers to Blackstone Credit, which is organized into two overarching strategies: private credit which includes mezzanine direct lending funds, private placement strategies, stressed and distressed strategies and energy strategies, and liquid credit which consists of CLOs, closed-ended funds, open ended funds and separately managed accounts. In addition, the segment includes an insurer-focused platform, an asset-based finance platform, and publicly traded master limited partnership investment platform. The Hedge Fund Solutions segment focuses on Blackstone Alternative Asset Management, which manages a broad range of commingled and customized hedge fund of fund solutions. It also includes a GP Stakes business and investment platforms that invest directly, as well as investment platforms that seed new hedge fund businesses and create alternative solutions through daily liquidity products. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY.

Blackstone Inc

Blackstone is trending as investors weigh the potential impact of a proposed federal ban on institutional investors purchasing single-family homes, which has triggered volatility in stocks linked to the housing sector. While the community is actively debating the legislative viability and localized market effects of this policy, many shareholders remain focused on the firm's broader diversification into AI infrastructure and energy as long-term catalysts for growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 5.5% - Here's What Happened

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 5.5% - Here's What Happened...

Amneal Pharmaceuticals Conference: Amneal 2.0 Targets 2026 Growth in Biosimilars, CREXONT and AvKARE Shift

Amneal Pharmaceuticals (NASDAQ:AMRX) used a recent investor presentation to highlight momentum coming out of fiscal 2025 and outline priorities for 2026 and beyond, emphasizing growth drivers across...

New Strong Buy Stocks for March 9th

ECG, AMRX, NESR, ACMR and HSY have been added to the Zacks Rank #1 (Strong Buy) List on March 9th, 2026.

Best Value Stocks to Buy for March 9th

AMRX, VET and NESR made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 9th, 2026.

Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. raised its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 2.3% in the third quarter, according to the company in its most recent disclosure with the...

Short Interest in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Drops By 16.4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) saw a large drop in short interest in the month of February. As of February 13th, there was short interest totaling 10,600,098 shares, a...

Truist Financial Issues Positive Forecast for Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price

Truist Financial lifted their target price on shares of Amneal Pharmaceuticals from $15.00 to $17.00 and gave the company a "buy" rating in a report on Monday...

Envestnet Asset Management Inc. Takes $1.61 Million Position in Amneal Pharmaceuticals, Inc. $AMRX

Envestnet Asset Management Inc. bought a new position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 3rd quarter, according to its most recent disclosure with the...

Amneal Pharmaceuticals (NASDAQ:AMRX) Releases FY 2026 Earnings Guidance

Amneal Pharmaceuticals (NASDAQ:AMRX) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.930-1.030 for the period, compared to the consensus estimate of 0.920. The company...

Amneal Pharmaceuticals Q4 Earnings Call Highlights

Amneal Pharmaceuticals (NASDAQ:AMRX) reported fourth-quarter and full-year 2025 results and outlined its 2026 outlook, highlighting growth across the business, expanding complex product launches, and...

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.17	--	--	N/A
Q4 '25	$0.18	$0.21	14.07%	BEAT
Q3 '25	$0.14	$0.17	22.88%	BEAT
Q2 '25	$0.17	$0.25	42.86%	BEAT
Q1 '25	$0.15	$0.21	43.18%	BEAT

AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest AMRX News

AMRXAmneal Pharmaceuticals Inc - Ordinary Shares - Class A